Alexandria Real Estate down 75% in 5 years but poised for recovery as life sciences market stabilizes

Alexandria Real Estate (ARE) has seen its stock decline 75% over five years due to oversupply, rising interest rates, and a slowdown in biotech funding. Despite recent challenges like falling rental rates and occupancy, ARE's high-quality assets are well-positioned for a recovery as new supply decreases. The life sciences real estate market is stabilizing with shrinking construction pipelines and early signs of recovery in key markets. The author remains bullish on ARE for the long term, recommending disciplined dollar-cost-averaging to benefit from the expected sector turnaround.